Covid inquiry: Failure to consider ‘potentially massive impact’ of lockdown pre-pandemic
The UK may not have been well prepared “at all”, says the lead lawyer for the Covid inquiry.
Similar Posts
Covid global health emergency is over, WHO says
Close to 20 million people are likely to have died during the last three years, says the WHO.
Experts Weigh In On The Salicylic Acid Body Wash Tweet With Over 15 Million Views
BuzzFeed may collect a share of sales or other compensation from the links on this page if you decide to shop from them. All products were independently selected by our editors, and the prices were accurate and items in stock at the time of publication. It’s rare for a skincare product to go viral on…
How AI is Transforming the Healthcare Industry: Revolutionary Shifts
AI is revolutionizing healthcare by enhancing diagnostics and personalizing treatment plans. It streamlines operations, improving patient outcomes and efficiency. Artificial Intelligence (AI) is making significant strides in the healthcare industry. AI-driven tools assist doctors in diagnosing diseases more accurately and swiftly. Machine learning algorithms analyze vast amounts of medical data, identifying patterns that may be…
Bad News — You’re Probably Wiping All Wrong. Here’s What You Should Be Doing.
You’ve probably heard that few things in life are certain except death and taxes, but we’d like to add something else to the list: cleaning up in the bathroom. So, since we have to do it, what’s the best technique? The preferred method of wiping “is not wiping,” nationally renowned anal surgeon Dr. Evan Goldstein…
MoonLake Immunotherapeutics explores sale | Reuters News Agency
Business & FinanceDealsHealth 14 July 2023, 5:43 pm 1 minute MoonLake Immunotherapeutics (MLTX.O), a developer of an antibody-derived treatment for inflammatory skin conditions, is working with an investment bank and having early-stage conversations with drugmakers interested in a potential acquisition. Market Impact MoonLake’s shares ended trading up 8.4% at $54.27 on the news on Friday,…
At-home health test maker Thorne explores sale | Reuters News Agency
Business & FinanceDealsHealth 21 July 2023, 6:41 pm 1 minute Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale. Market Impact Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million….
